Back to News
Market Impact: 0.35

AMGN Factor-Based Stock Analysis

AMGN
Company FundamentalsAnalyst InsightsHealthcare & BiotechDerivatives & VolatilityCapital Returns (Dividends / Buybacks)Market Technicals & Flows
AMGN Factor-Based Stock Analysis

Validea's guru fundamental report assigns Amgen (AMGN) an 87% rating using Pim van Vliet's Multi-Factor Investor model, which targets low volatility stocks with strong momentum and high net payout yields. This score indicates 'some interest' in the large-cap biotechnology firm, primarily driven by its low volatility profile, despite neutral performance on momentum and net payout yield criteria, positioning AMGN as a potential candidate for conservative equity strategies.

Analysis

Amgen, Inc. (AMGN) has been assigned a favorable 87% rating by Validea's Multi-Factor Investor model, which is based on the published strategy of Pim van Vliet. This score signifies 'some interest' from the model, approaching the 'strong interest' threshold of 90%. The rating is primarily driven by the stock's strong performance on low-volatility criteria, as it received a 'PASS' on its standard deviation metric, aligning with the model's core focus on conservative, low-risk equities. However, this strength is tempered by 'NEUTRAL' ratings for both its 'Twelve Minus One Momentum' and 'Net Payout Yield'. This indicates that while the large-cap biotechnology firm exhibits desirable stability, it does not currently possess the strong price momentum or high shareholder yield that are the other key components of this specific quantitative strategy, positioning it as a potentially suitable holding for risk-averse investors.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment